Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Oct 31, 2025 | (Q1)Jul 31, 2025 | (FY)Apr 30, 2025 | (Q4)Apr 30, 2025 | (Q3)Jan 31, 2025 | (Q2)Oct 31, 2024 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 28.47%-322.14K | -110.95%-145.75K | 117.57%245.97K | 61.68%-553.61K | 48.84%-80.99K | -8.94%-450.34K | 115.75%1.33M | -155.25%-1.4M | -108.90%-1.44M | -57.60%-158.29K |
| Net income from continuing operations | 110.80%26.74K | 67.10%-93.47K | 22.48%-509.82K | 820.07%129.81K | 64.15%-107.91K | -76.05%-247.6K | -43.48%-284.12K | -1.11%-657.66K | 74.93%-18.03K | -81.27%-300.97K |
| Operating gains losses | --0 | ---110.76K | ---86.2K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -38.37%10.53K | 86.19%10.53K | -12.53%45.49K | -12.53%11.37K | -12.54%11.37K | 48.20%17.09K | -60.91%5.66K | -10.15%52.01K | -10.15%13K | -10.15%13K |
| Unrealized gains and losses of investment securities | ---478.08K | ---24.42K | -314.81%-475.98K | -314.81%-475.98K | --0 | --0 | --0 | 352.89%221.58K | 437.24%221.58K | --0 |
| Remuneration paid in stock | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -97.66%758 | -95.05%758 | --0 |
| Other non cashItems | -564.43%-9.14K | 454.40%11.84K | 103.41%7.52K | 153.20%121.56K | -4,896.67%-118.14K | -24.94%1.97K | -22.97%2.14K | -1,869.09%-220.64K | -217.61%-228.5K | 101.31%2.46K |
| Change In working capital | 96.57%-7.6K | -96.23%60.53K | 258.99%1.26M | 90.64%-134.24K | -89.19%13.76K | 22.69%-221.8K | 101.50%1.61M | -1,014.33%-795.6K | -144.36%-1.43M | 67.08%127.22K |
| -Change in receivables | 405.57%19.36K | -100.04%-1.26K | 225.08%2.92M | 95.37%-139.5K | 72.77%-4.33K | -104.51%-6.33K | 449.94%3.07M | -7,343.50%-2.33M | -312.47%-3.02M | -112.87%-15.9K |
| -Change in prepaid assets | -368.24%-87.25K | 101.10%23.73K | -79.30%9.13K | -111.40%-56.69K | 112.55%21.5K | 117.11%32.53K | 112.86%11.8K | 1,268.28%44.13K | 1,063.53%497.24K | -602.42%-171.26K |
| -Change in payables and accrued expense | ---- | ---- | -211.32%-1.66M | ---- | ---- | ---- | ---- | 1,197.49%1.49M | ---- | ---- |
| -Change in other current liabilities | 124.32%60.3K | 102.58%38.05K | ---- | ---- | -101.09%-3.41K | -4.60%-247.99K | -544.76%-1.47M | ---- | ---- | 1,463.34%314.39K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 28.47%-322.14K | -110.95%-145.75K | 117.57%245.97K | 69.98%-433.67K | -26.94%-200.93K | -8.94%-450.34K | 115.75%1.33M | -155.25%-1.4M | -188.82%-1.44M | 45.76%-158.29K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -289.09%-814K | 59.21%-96.07K | 209.80%563.71K | -56.59%397.79K | 95.76%-29.03K | 1,094.87%430.49K | 66.43%-235.54K | 77.85%-513.37K | 62.00%916.29K | 0.50%-684.71K |
| Net PPE purchase and sale | -245.94%-628.24K | 0.54%-234.25K | 166.15%339.61K | -81.04%173.69K | 95.76%-29.03K | 1,094.87%430.49K | 66.43%-235.54K | 77.85%-513.37K | 62.00%916.29K | 0.50%-684.71K |
| Net investment purchase and sale | ---185.76K | --138.18K | --224.1K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -289.09%-814K | 59.21%-96.07K | 209.80%563.71K | -56.59%397.79K | 95.76%-29.03K | 1,094.87%430.49K | 66.43%-235.54K | 77.85%-513.37K | 105.36%916.29K | -20.39%-684.71K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 37,193.67%3.89M | 0.00%-10.5K | -1.45%-42K | 0.00%-10.5K | 0.00%-10.5K | 0.00%-10.5K | -6.06%-10.5K | -19.65%-41.4K | 64.65%-10.5K | -10.5K |
| Net issuance payments of debt | 0.00%-10.5K | 0.00%-10.5K | -1.45%-42K | 0.00%-10.5K | 0.00%-10.5K | 0.00%-10.5K | -6.06%-10.5K | -4.55%-41.4K | 64.65%-10.5K | ---10.5K |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 37,193.67%3.89M | 0.00%-10.5K | -1.45%-42K | 0.00%-10.5K | 0.00%-10.5K | 0.00%-10.5K | -6.06%-10.5K | -19.65%-41.4K | 64.65%-10.5K | ---10.5K |
| Net cash flow | ||||||||||
| Beginning cash position | -16.77%2.83M | 33.22%3.08M | -45.82%2.31M | 10.16%3.13M | -9.12%3.37M | -18.58%3.4M | -45.82%2.31M | -40.48%4.27M | -37.52%2.84M | -28.91%3.7M |
| Current changes in cash | 9,190.48%2.76M | -123.26%-252.32K | 139.28%767.68K | 91.18%-46.39K | 72.26%-240.46K | 93.50%-30.35K | 1,245.37%1.08M | 32.63%-1.95M | -91.08%-525.7K | -29.53%-866.78K |
| End cash Position | 65.95%5.59M | -16.77%2.83M | 33.22%3.08M | 33.22%3.08M | 10.16%3.13M | -9.12%3.37M | -18.58%3.4M | -45.82%2.31M | -45.82%2.31M | -37.52%2.84M |
| Free cash from | -181.75%-950.39K | -134.69%-380K | 87.96%-298.49K | 24.45%-826.59K | 72.72%-229.96K | 26.13%-337.31K | 1,391.43%1.1M | 16.99%-2.48M | -1,924.37%-1.09M | 12.28%-842.99K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.